Ugli Tablet 15 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
YuYu Pharmaceutical Co., Ltd.
MFDS item code 201903308 · Approved 2019.05.22
This product's status changed to Expired on 2024.05.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement in type 2 diabetes (blood sugar control)
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be administered as monotherapy along with dietary and exercise regimens, and in cases of insufficient improvement in blood sugar, it can be combined with sulfonylureas, metformin, or insulin. Nutritional counseling, weight loss, and regular exercise also play a vital role in diabetes treatment. This comprehensive treatment approach helps effectively regulate blood sugar and maintain the efficacy of drug therapy. Therefore, this medication is used to improve blood sugar control in patients with type 2 diabetes.
This medication is administered orally once daily without regard to meals. As monotherapy, it is initiated at 15 mg orally once daily, and if adequate effectiveness is not achieved, the dose may be increased to 30 mg once daily. In combination therapy, 15 mg orally once daily is also administered. The maximum recommended dosage does not exceed 30 mg once daily.
There is no experience in pediatric patients under 18 years of age, so use is not recommended.
This medication is used for treating type 2 diabetes and requires insulin to lower blood sugar levels. It may worsen or newly induce heart failure, thus it should not be used in patients with heart failure, and symptoms of heart failure such as sudden weight gain, shortness of breath, and edema should be closely monitored during treatment. Fluid retention may occur, which can lead to swelling, so if there is severe swelling or signs of heart failure, consult a doctor immediately. This medication should not be administered to patients with bladder cancer or a history of bladder cancer, and if symptoms such as hematuria or urinary difficulties develop during treatment, inform a physician immediately. Patients with impaired liver function or severe renal impairment should generally avoid this medication, and if symptoms of liver dysfunction appear, treatment should be stopped, and medical consultation is advised. The risk of hypoglycemia may increase when used with other blood glucose-lowering agents, especially insulin or sulfonylureas, so symptoms of hypoglycemia should be monitored, and doses of other medications may need adjustment. In premenopausal women, this medication may promote ovulation, increasing the risk of pregnancy, so appropriate contraception should be employed. Use with caution in elderly patients or those with reduced kidney function, and regular blood glucose and liver function tests are essential. During treatment, weight gain and edema may occur, so monitor weight changes closely, and consult a doctor if any abnormalities are observed. No specific symptoms may present in case of overdose; however, appropriate treatment and observation based on clinical symptoms are necessary. This medication is not recommended for use in children, as safety and efficacy have not been established. Lastly, this medication must be taken according to a physician's prescription and instructions, and any uncomfortable symptoms or adverse reactions experienced during use should be reported to medical staff immediately.
Congestive heart failure, worsening of heart failure, edema (peripheral edema, generalized edema, pitting edema, fluid retention), severe edema, cardiac dysfunction, stroke, myocardial infarction, chest tightness, difficulty breathing, dyspnea, severe liver abnormalities (liver failure, jaundice), hives, severe allergic reactions, hives, hypertension, stroke, severe neurological symptoms, severe skin adverse reactions, bladder cancer, urinary abnormalities, cardiovascular death, severe low
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a light-resistant, airtight container and kept away from humid areas. The storage temperature should be generally between 15 to 30 degrees Celsius, ideally at about 25 degrees Celsius in a cool place.
White round tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
YuYu Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.